Theragen Etex Co.Ltd (066700) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.020x

Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.08 Billion ≈ $2.09 Million USD) by net assets (₩152.04 Billion ≈ $103.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Theragen Etex Co.Ltd to measure how much of total assets are equity-financed.

Theragen Etex Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Theragen Etex Co.Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Equity Metals Corp V:EQTY	-0.520x
Seplat Petroleum Development Company PLC LSE:SEPL	0.367x
M.J. International Co Ltd TW:8466	-0.013x
Fuel Tech Inc NASDAQ:FTEK	-0.022x
HBR Realty Empreendimentos Imobiliários S.A SA:HBRE3	0.065x
Namyang Dairy Products Co Ltd Peffered Series 1 KO:003925	0.003x
HY Electronic Cayman Ltd TW:6573	0.298x
Dunia Virtual Online Tbk Pt JK:AREA	0.063x

Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Theragen Etex Co.Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.17 Billion ≈ $107.87 Million	₩10.97 Billion ≈ $7.44 Million	0.069x	+403.28%
2024-12-31	₩130.54 Billion ≈ $88.47 Million	₩1.79 Billion ≈ $1.21 Million	0.014x	-82.72%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	₩12.12 Billion ≈ $8.22 Million	0.079x	+18.67%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	₩9.59 Billion ≈ $6.50 Million	0.067x	+271.32%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	₩4.01 Billion ≈ $2.72 Million	0.018x	-49.11%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	₩13.23 Billion ≈ $8.96 Million	0.035x	+12645.45%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	₩37.69 Million ≈ $25.54K	0.000x	+100.12%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	₩-18.58 Billion ≈ $-12.59 Million	-0.230x	-1223.09%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	₩1.78 Billion ≈ $1.20 Million	0.020x	+117.59%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.116x	-1825.75%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	₩-415.37 Million ≈ $-281.49K	-0.006x	-1338.61%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	₩39.95 Million ≈ $27.08K	0.000x	-99.59%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	₩3.14 Billion ≈ $2.13 Million	0.120x	--

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$42.03 Million

₩62.02 Billion KRW

Market Cap Rank

#22499 Global

#1402 in Korea

Share Price

₩2035.00

Change (1 day)

+3.72%

52-Week Range

₩1888.00 - ₩3315.00

All Time High

₩21800.00